Iris Shen, a 17-year-old student from Texas, has been awarded $150,000 in a national science competition for her innovative research into potential blood cancer treatments. Shen's project utilized freshwater clams as a novel model to test various drug compounds, identifying one treatment that demonstrated behavior similar to what is observed in human cell tests. This achievement highlights the potential for alternative, cost-effective models in preliminary drug screening.

Shen, a student at Plano East Senior High School, presented her findings at the Regeneron Science Talent Search, a competition recognized as one of the most prestigious for high school students in the United States. Her methodology involved exposing clams, specifically the Asiatic clam (Corbicula fluminea), to a range of potential therapeutic compounds. The objective was to observe cellular responses and determine if these invertebrate models could provide relevant insights into drug efficacy against blood cancer cells.

The research focused on identifying compounds that could inhibit cancer cell growth or induce programmed cell death (apoptosis). Shen discovered that one particular compound elicited a response in the clam cells that paralleled previously reported effects in human leukemia cell lines. This finding suggests that clams could serve as a valuable initial screening tool, potentially accelerating the early stages of drug development by offering a simpler and more accessible testing environment than traditional vertebrate models or complex cell cultures.

Key details of Shen's research:

  • Model Organism: Freshwater clams (Corbicula fluminea) were chosen due to their cellular similarities to human cells in certain physiological pathways and their availability.
  • Disease Focus: The study targeted potential treatments for blood cancers, a group of malignancies affecting the blood, bone marrow, and lymphatic system.
  • Key Finding: One tested compound demonstrated a noteworthy effect on clam cells, showing behavior consistent with its known or hypothesized interaction with human cancer cells. This included observations related to cellular viability and proliferation.
  • Potential Impact: The use of clams could offer a more ethical, affordable, and less resource-intensive option for initial drug screenings compared to mammalian models.

The $150,000 award recognizes the originality, scientific rigor, and potential impact of Shen's work. The Regeneron Science Talent Search, a program of Society for Science, has historically identified young scientists whose projects demonstrate exceptional promise in addressing significant global challenges. Shen's research contributes to the ongoing efforts in oncology to find new and more effective treatments for blood cancers, an area where innovation in drug discovery is consistently needed.

Following her recognition, Iris Shen plans to continue her academic pursuits with a focus on biomedical research. The prize money is intended to support her higher education and future scientific endeavors, potentially allowing her to further explore the implications of her findings and contribute to the development of novel therapeutic strategies.